NYSE:BTX Brooklyn ImmunoTherapeutics (BTX) Stock Price, News & Analysis → Biden out June 13; Kamala won’t replace him? (From Paradigm Press) (Ad) Free BTX Stock Alerts $1.77 -0.06 (-3.28%) (As of 04/30/2024 ET) Add Compare Share Share Today's Range$1.75▼$1.7750-Day Range$1.55▼$4.1052-Week Range$0.17▼$10.10Volume2,087 shsAverage Volume515,543 shsMarket Capitalization$104.12 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsHeadlinesSocial MediaStock AnalysisChartCompetitorsHeadlinesSocial Media Get Brooklyn ImmunoTherapeutics alerts: Email Address Ad Wall Street StarAI finds its first serious applicationAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry About Brooklyn ImmunoTherapeutics Stock (NYSE:BTX)Eterna Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in creating transformative regenerative medicine treatments for cancer, blood disorders, and monogenic diseases. It offers IRX-2, a human cell-derived cytokine therapy, studying the safety and efficacy of IRX-2 in patients with head and neck cancer in Phase 2B. The company is headquartered in San Diego, CA.Read More BTX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BTX Stock News HeadlinesApril 28, 2024 | americanbankingnews.comStockNews.com Initiates Coverage on Brooklyn ImmunoTherapeutics (NYSE:BTX)April 20, 2024 | americanbankingnews.comBrooklyn ImmunoTherapeutics (NYSE:BTX) Research Coverage Started at StockNews.comApril 30, 2024 | DTI (Ad)the harsh reality of the stock marketOK, you’re not supposed to say this In fact, maverick investor Graham Lindman says it’s become the silent elephant in the room that everyone is pretending isn’t there. But he just said it: Most stocks suck. And he isn’t saying that figuratively or subjectively… You see, 96% of stocks underperform. Just 4% of “Apex Stocks” generate virtually all the wealth.December 19, 2023 | abcnews.go.com'Brooklyn Nine-Nine' star Andre Braugher dies at 61December 2, 2023 | nypost.comSabrina Carpenter blows off Catholic Church scandal: ‘Jesus was a carpenter’December 2, 2023 | travel.usnews.comBrooklyn BridgeNovember 8, 2023 | time.comBrooklyn Bedding Coupon for NovemberSeptember 28, 2023 | nypost.comDozens of vendors still swarm Brooklyn Bridge in free-for-all — selling illegal cocktails, pics with live snake: photosApril 30, 2024 | DTI (Ad)the harsh reality of the stock marketOK, you’re not supposed to say this In fact, maverick investor Graham Lindman says it’s become the silent elephant in the room that everyone is pretending isn’t there. But he just said it: Most stocks suck. And he isn’t saying that figuratively or subjectively… You see, 96% of stocks underperform. Just 4% of “Apex Stocks” generate virtually all the wealth.August 29, 2023 | mirror.co.ukBrooklyn Beckham's wife Nicola Peltz 'to be grilled on camera' over bitter wedding spatJune 29, 2023 | health.usnews.comBrooklyn Hospital CenterJune 22, 2023 | ft.comPure joy: the best of Brooklyn’s cool natural wine sceneJune 8, 2023 | forbes.comBest Moving Companies In Brooklyn, New York June 2023May 7, 2023 | usnews.comBrooklyn Technical High SchoolMay 6, 2023 | usnews.comBrooklyn Preparatory High SchoolMarch 31, 2023 | dailymail.co.ukBrooklyn Beckham: Latest news, views, gossip, photos and videoMarch 18, 2023 | mirror.co.ukBillionaire heiress Nicola Peltz and Brooklyn Beckham saving to buy their 'dream house'March 11, 2023 | mirror.co.ukVictoria Beckham 'fears for son Brooklyn and his wife Nicola' amid wedding lawsuitMarch 1, 2023 | nytimes.comIn Brooklyn, a Tiny Apartment and a Neighborhood Filled With FamiliesMarch 1, 2023 | nypost.comBrooklyn’s priciest rental of 2023 has quickly found a tenantFebruary 26, 2023 | cbsnews.comPolice ask for help identifying driver at the scene of shooting, carjacking in Brooklyn ParkFebruary 23, 2023 | foxnews.comBrooklyn Nets sign head coach Jacque Vaughn to multiyear contract extensionFebruary 19, 2023 | nytimes.comFor Strictly Observant Jews in Brooklyn, the Sabbath ExpandsFebruary 5, 2023 | yahoo.com7 Times Brooklyn Beckham Got Roasted for His Questionable Cooking SkillsJanuary 30, 2023 | dailymail.co.ukCruz Beckham teaches brother Brooklyn how to cook as he whips up a pizza on family outing in MiamiJanuary 28, 2023 | nypost.comLike Brooklyn Beckham, I’m a ‘one of the girls’ husband — and I love itNovember 12, 2022 | mirror.co.ukVictoria Beckham ignores Brooklyn and Nicola's anniversary posts as she teases book clubSee More Headlines Receive BTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Brooklyn ImmunoTherapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNYSE SectorInformation Industry Television Broadcasting Sub-IndustryN/A Current SymbolNYSE:BTX CUSIPN/A CIKN/A WebN/A Phone(212) 582-1199FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares58,826,000Free FloatN/AMarket Cap$107.65 million OptionableNo Data Beta4.61 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMatthew AngelPresident, Chief Executive Officer & DirectorAndrew C. JacksonChief Financial OfficerRoger SidhuChief Medical OfficerJay SialChief Administrative OfficerSandra GurrolaPrincipal Accounting Officer & VP-FinanceKey CompetitorsCinedigmNASDAQ:CIDMAlfiNASDAQ:ALFIWNortonLifeLockNASDAQ:NLOKView All Competitors BTX Stock Analysis - Frequently Asked Questions How have BTX shares performed in 2024? Brooklyn ImmunoTherapeutics' stock was trading at $4.1020 at the beginning of 2024. Since then, BTX shares have decreased by 56.9% and is now trading at $1.77. View the best growth stocks for 2024 here. How do I buy shares of Brooklyn ImmunoTherapeutics? Shares of BTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:BTX) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersThe Gold Grab of the CenturyColonial MetalsProtect Your Bank Account Before It’s Too LateWeiss RatingsTrump’s last act as President Porter & CompanyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsIs Tesla going out of business?DTIElon Musk Secret Crypto Plot ExposedCrypto 101 MediaHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceREAD THIS – If You Missed Out On The AI BoomBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Brooklyn ImmunoTherapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
